PSOGI World News – Looking at Alternatives Intraperitoneal Treatments
Peritoneal Surface Oncology Group International shared a post on LinkedIn:
“PSOGI WORLD NEWS
Summer edition
Stepping away from the heat and looking at alternative intraperitoneal treatments
Section 1
From Bench to Belly: Intraperitoneal Adoptive Cell Therapies
– Ian A. Goldlust and Steven Rosenberg
Section 2
Exposition of progress and productivity of an established PSM Center of Excellence
Intra-Peritoneal Immunotherapy: Past, Present and Future Opportunities
– Patrick L. Wagner and David L Bartlett
Section 3
Listing of upcoming events
The 15th PSOGI International Congress on Peritoneal Surface Malignancies PSOGI 2025, PSOGI BARCELONA
PSOGI-Barcelona-2025. A Ten-Point Guide to the Congress
– Aditi Bhatt
Section 4
Alternatives to traditional HIPEC
CAR T-cell Treatment for Peritoneal Metastases
– Else Marit Inderberg, Sébastien Wälchli, and Kjersti Flatmar
Section 5
Pioneers of progress in peritoneal surface malignancy
Intraperitoneal Immune Modulation with Toll-like Receptor Agonists to Prevent- Postop Recurrence after Surgical Treatment of Peritoneal Metastases
– Wim Ceelen
Section 6
Focus on active PSM protocols
Target Radiotherapy for Peritoneal Surface Malignancies: Radioimmunotherapy and Radioligand therapy
– Shigeki Kusamura
To receive a copy write to [email protected].”
More posts featuring PSOGI on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023